News

Gefitinib Offers Palliative Care in Advanced Esophageal Cancer


 

AT THE EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY CONGRESS

Cancer Research UK sponsored the trial. Dr. Ferry reported grant support, honoraria, and an advisory relationship with AstraZeneca in the development of gefitinib.

Pages

Recommended Reading

Amgen Rethinks Ganitumab After Failure in Pancreatic Cancer
MDedge Hematology and Oncology
Esophageal Cancers Reported After Radiofrequency Ablation
MDedge Hematology and Oncology
Ablation Cost Effective for High-Grade Dysplasia in Barrett's Esophagus
MDedge Hematology and Oncology
ASCO 2012: Three Drugs for Colorectal Cancer
MDedge Hematology and Oncology
Upper GI Cancer Risk Elevated in AIDS
MDedge Hematology and Oncology
Robotic Device for Gastric Neoplasia Found Safe in Five Patients
MDedge Hematology and Oncology
Long-Term Follow-Up Warranted After Gastric MALT Lymphoma Remission
MDedge Hematology and Oncology
Two Common Genetic Variants Linked to Barrett's Esophagus
MDedge Hematology and Oncology
FDA Approves Regorafenib for Metastatic Colorectal Cancer
MDedge Hematology and Oncology
Cetuximab plus FOLFIRI in first-line treatment of KRAS mutation-negative, EGFR-positive metastatic colorectal cancer
MDedge Hematology and Oncology